Namibian Market Community
Our community narratives are driven by numbers and valuation.
Namibian Investing Ideas
Global Weekly Picks
Global Community
Luca Mining, $176M Revenue, Strong FCF, 200K Oz AuEq Vision & Debt-Free by Mid-2026
This mining company’s outlook changes fast if gold and silver prices rise and it hits its production and cost targets. See how a ramp-up at its operations, plus debt payoff or new discoveries, could boost cash generation—or how missed guidance could derail it.Read more
PROCEPT BioRobotics sees 17.69% revenue growth and aims for 12.94% profit margin
I have been an investor in PRCT since before IPO. The wild fluctuations in share price recently make no sense.Read more
UUE Holdings Trading at Deep Value Despite Strong Growth Prospects
UUE Holdings lands steady utility and power projects and is pushing into data-centre and fibre buildouts, where demand keeps rising across the region. The twist is that the market still treats it like a slow, risky contractor, even as its work pipeline and profits look like they’re building momentum.Read more
A SPAC in the Endgame Between Lifeboat and Siren Song
The Metaphor Upfront: Investing in DTSQ is like buying a ticket on a lifeboat whose captain has just decided to purchase a luxuriously labeled but barely inspected cargo ship in the middle of the open sea. Those who disembark in time get their money back plus a small interest premium.Read more
Mastercard: The Best Dividend Stock You're Ignoring
What Does Mastercard Do? Most people should already be familiar with this company, but for those who aren't: Mastercard runs the rails connecting banks, merchants, and the billions of cards carrying its brand.Read more
VTEX acquisition pivots KITZ to global #2 in semiconductor vacuum valves
KITZ makes a bold move into the heart of the chipmaking supply chain by buying VTEX, turning it into a serious second-choice supplier for equipment makers that want an alternative to the dominant player. The deal is timed when the industry is coming off a lull, so a rebound in chip-factory spending could make this shift look bigger than the market expects.Read more
Strong in favor of diversity in value portfolio
A healthcare device maker looks like a steady long-term add for someone trying to spread risk beyond big drug companies, helped by a recent buyout that broadens its brain-related tech offerings. The appeal is slow-and-steady growth and a long history of raising its payout, though the outlook isn’t flashy and some experts sound cautious.Read more
